Jeffrey A. Meckler, CEO and Director at Indaptus Therapeutics, Inc. (INDP), bought 10,308 shares at $2.80 ($29K) on 2022-09-08, disclosed to the SEC on 2022-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2024-09-30 | $562K | — | Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-08 | $25K | — | Filing → |